Market Overview

Iradimed Sinks 30% On Sharply Cut Guidance


Iradimed Corp (NASDAQ: IRMD) shares are trading lower by $5.76 (33 percent) at $11.25 in Tuesday's session. The catalyst for the decline is sharply lower guidance announced after Monday's close.

Q3 EPS guidance was slashed from $0.91-$0.93 to $0.60-$0.63 and FY sales guidance from $9.90-$10 million to $7.50-$7.60 million.

After drifting lower in after-hours and pre-market trading, the issue opened sharply lower ($12.24 vs. Monday's close of $17.01) and could only manage a $0.30 bounce to $12.54. Instantly, panic-sellers flooded the issue, taking it all the way to $9.76 in just two minutes.

The current low coincides with its December 15, 2014 low of $9.79.

Since rebounding from that depressed level, the issue has consolidated at the $11.20 area over the past hour.

Posted-In: News Guidance Technicals Intraday Update Movers Trading Ideas


Related Articles (IRMD)

View Comments and Join the Discussion!

Top Performing Industries For October 4, 2016

Federal Reserve Being 'Held Hostage' By Global Markets